The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The resistance was probably caused by mutations in tcaA (sibstitutions in TcaA D230E or F290S), tcaB (substitution in TcaB Y6R), lytS (LytS substitutions: P315R, A318Q, A319L, I320S, andV321M), and rhoR (substitutions in RhoR: V186I, L144I and V535M) genes [84].”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [84]
In the citing paper
“VISA was also described in ST1-IV, ST30-IV, ST59-IV, ST72-IV, ST81-IV, ST45, ST228-I, ST398, ST900-III, ST1301-II [84,85,86,87].”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Mechanisms of vancomycin resistance in Staphylococcus aureus
Gardete, S., & Tomasz, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68834 · Cited by 565
Wootton, M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.4.399 · Cited by 414
Research works printed but not linked: 68
- M Melzer, 2003, Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia, Clin Infect Dis, 37, 1453, 10.1086/379321 · DOI · Paper page
- A Soriano, 2008, Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia, Clin Infect Dis, 46, 193, 10.1086/524667 · DOI · Paper page
- KH Song, 2017, Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections, Antimicrob Agents Chemother, 61
- HJ Chang, 2012, Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study, J Antimicrob Chemother, 67, 736, 10.1093/jac/dkr531 · doi:10.1093/jac/dkr531
- KY Chen, 2013, Relationship of teicoplanin MICs to treatment failure in teicoplanin-treated patients with methicillin-resistant Staphylococcus aureus pneumonia, J Microbiol Immunol Infect, 46, 210, 10.1016/j.jmii.2012.06.010 · DOI
- J Cepeda, 2003, Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit, J Antimicrob Chemother, 52, 533, 10.1093/jac/dkg369 · doi:10.1093/jac/dkg369
- DM Gomes, 2015, Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus, Pharmacotherapy, 35, 424, 10.1002/phar.1577 · DOI
- S Zhang, 2015, Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates, PLoS One, 10, e0136082, 10.1371/journal.pone.0136082 · DOI · Paper page
- SJ van Hal, 2011, Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infections, PLoS One, 6, e21217, 10.1371/journal.pone.0021217 · DOI
- AM Casapao, 2013, Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream Infection, Antimicrob Agents Chemother, 57, 4252, 10.1128/AAC.00380-13 · DOI
- A Dhand, 2014, Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy, F1000 Med Rep, 4, 4
- K Hiramatsu, 2001, Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance, Lancet Infect Dis, 1, 147, 10.1016/S1473-3099(01)00091-3 · DOI · Paper page
- S Deresinski, 2013, The multiple paths to heteroresistance and intermediate resistance to vancomycin in Staphylococcus aureus, J Infect Dis, 208, 7, 10.1093/infdis/jit136 · DOI
- J Xu, 2018, Phenotypic and Molecular Characterisation of Staphylococcus aureus with Reduced Vancomycin Susceptibility Derivated in Vitro, Open Med (Wars), 13, 475, 10.1515/med-2018-0071 · DOI
- L Cui, 2006, Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus, Antimicrob Agents Chemother, 50, 428, 10.1128/AAC.50.2.428-438.2006 · DOI · Paper page
- S Boyle-Vavra, 2013, VraT/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus, Antimicrob Agents Chemother, 57, 83, 10.1128/AAC.01651-12 · DOI
- AA Elsaghier, 2002, Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection, J Antimicrob Chemother, 49, 423, 10.1093/jac/49.2.423 · doi:10.1093/jac/49.2.423
- K Szymanek-Majchrzak, 2018, Characteristics of glycopeptide-resistant Staphylococcus aureus strains isolated from inpatients of three teaching hospitals in Warsaw, Poland, Antimicrob Resist Infect Control, 7, 105, 10.1186/s13756-018-0397-y · DOI · Paper page
- Y Kato, 2010, Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR, J Antimicrob Chemother, 65, 37, 10.1093/jac/dkp394 · DOI
- N McCallum, 2010, Regulation of antibiotic resistance in Staphylococcus aureus, Int J Med Microbiol, 300, 118, 10.1016/j.ijmm.2009.08.015 · DOI
- H Maki, 2004, tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus, Antimicrob Agents Chemother, 48, 1953, 10.1128/AAC.48.6.1953-1959.2004 · DOI
- M Brandenberger, 2000, Inactivation of a novel three-cistronic operon tcaR-tcaA-tcaB increases teicoplanin resistance in Staphylococcus aureus, Biochim Biophys Acta, 1523, 135, 10.1016/S0304-4165(00)00133-1 · DOI
- M Wootton, 2005, Expression of tcaA and mprF and glycopeptide resistance in clinical glycopeptide-intermediate Staphylococcus aureus (GISA) and heteroGISA strains, Biochim Biophys Acta, 1726, 326, 10.1016/j.bbagen.2005.09.002 · doi:10.1016/j.bbagen.2005.09.002
- C Liu, 2003, Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods, Antimicrob Agents Chemother, 47, 3040, 10.1128/AAC.47.10.3040-3045.2003 · DOI · Paper page
- F Brunet, 1990, Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin, Eur J Clin Microbiol Infect Dis, 9, 145, 10.1007/BF01963643 · DOI
- K Hiramatsu, 2001, Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance, Lancet Infect Dis, 1, 147, 10.1016/S1473-3099(01)00091-3 · DOI · Paper page
- K Sieradzki, 1998, Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci, Antimicrob Agents Chemother, 42, 100, 10.1128/AAC.42.1.100 · doi:10.1128/aac.42.1.100
- R Khatib, 2015, Screening for Intermediately Vancomycin-Susceptible and Vancomycin-Heteroresistant Staphylococcus aureus by Use of Vancomycin-Supplemented Brain Heart Infusion Agar Biplates: Defining Growth Interpretation Criteria Based on Gold Standard Confirmation, J Clin Microbiol, 53, 3543, 10.1128/JCM.01620-15 · DOI
- SW Satola, 2011, Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method, J Clin Microbiol, 49, 177, 10.1128/JCM.01128-10 · DOI
- CA Rodriguez, 2012, Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model, Antimicrob Agents Chemother, 56, 243, 10.1128/AAC.05129-11 · DOI
- CJ Chen, 2015, Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia, J Antimicrob Chemother, 70, 2965, 10.1093/jac/dkv225 · DOI
- M Goudarzi, 2017, Molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from patients with bacteremia based on MLST, SCCmec, spa, and agr locus types analysis, Microb Pathog, 104, 328, 10.1016/j.micpath.2017.01.055 · doi:10.1016/j.micpath.2017.01.055
- K Zhang, 2005, Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus, J Clin Microbiol, 43, 5026, 10.1128/JCM.43.10.5026-5033.2005 · DOI · Paper page
- E Ghaznavi-Rad, 2010, A simplified multiplex PCR assay for fast and easy discrimination of globally distributed staphylococcal cassette chromosome mec types in meticillin-resistant Staphylococcus aureus, J Med Microbiol, 59, 1135, 10.1099/jmm.0.021956-0 · doi:10.1099/jmm.0.021956-0
- D Harmsen, 2003, Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management, J Clin Microbiol, 41, 5442, 10.1128/JCM.41.12.5442-5448.2003 · DOI · Paper page
- MC Enright, 2000, Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus, J Clin Microbiol, 38, 1008, 10.1128/JCM.38.3.1008-1015.2000 · DOI · Paper page
- B Ribeiro-Gonçalves, 2016, PHYLOViZ Online: web-based tool for visualization, phylogenetic inference, analysis and sharing of minimum spanning trees, Nucleic Acids Res, 44, W246, 10.1093/nar/gkw359 · DOI · Paper page
- A.R. Wattam, 2013, PATRIC, the bacterial bioinformatics database and analysis resource, Nucleic Acids Res, 42, D581, 10.1093/nar/gkt1099 · DOI · Paper page
- RK Aziz, 2008, The RAST Server: rapid annotations using subsystems technology, BMC genomics, 9, 75, 10.1186/1471-2164-9-75 · DOI · Paper page
- R Overbeek, 2013, The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST), Nucleic acids research, 42, D206, 10.1093/nar/gkt1226 · DOI · Paper page
- T Brettin, 2015, RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes, Scientific reports, 5, 8365, 10.1038/srep08365 · DOI · Paper page
- PC Ng, 2001, Predicting deleterious amino acid substitutions, Genome Res, 11, 863, 10.1101/gr.176601 · DOI · Paper page
- T Huang, 2010, Prediction of deleterious non-synonymous SNPs based on protein interaction network and hybrid properties, PLoS One, 5, e11900, 10.1371/journal.pone.0011900 · DOI
- P Shannon, 2003, Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks, Genome Research, 13, 2498, 10.1101/gr.1239303 · DOI · Paper page
- D Szklarczyk, 2015, STRING v10: protein-protein interaction networks, integrated over the tree of life, Nucleic Acids Research, 43, D447, 10.1093/nar/gku1003 · DOI · Paper page
- A Renzoni, 2006, Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus, Antimicrob Agents Chemother, 50, 3048, 10.1128/AAC.00113-06 · DOI
- KJ Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 · DOI · Paper page
- P Vaudaux, 2002, Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes, Infect Immun, 70, 5428, 10.1128/IAI.70.10.5428-5437.2002 · DOI · Paper page
- TP Lodise, 2008, Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin, Antimicrob Agents Chemother, 52, 3315, 10.1128/AAC.00113-08 · DOI · Paper page
- G Sakoulas, 2004, Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia, J Clin Microbiol, 42, 2398, 10.1128/JCM.42.6.2398-2402.2004 · DOI · Paper page
- YC Yeh, 2012, Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia, J Microbiol Immunol Infect, 45, 214, 10.1016/j.jmii.2011.11.006 · doi:10.1016/j.jmii.2011.11.006
- K Hiramatsu, 2014, Vancomycin-intermediate resistance in Staphylococcus aureus, J Glob Antimicrob Resist, 2, 213, 10.1016/j.jgar.2014.04.006 · DOI
- JH Song, 2004, Asian Network for Surveillance of Resistant Pathogens Study Group. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin, Antimicrob Agents Chemother, 48, 4926, 10.1128/AAC.48.12.4926-4928.2004 · DOI
- CN Chaudhari, 2015, Heterogeneous vancomycin-intermediate among methicillin resistant Staphylococcus aureus, Med J Armed Forces India, 71, 15, 10.1016/j.mjafi.2014.03.008 · DOI
- A Singh, 2015, Increasing Trend of Heterogeneous Vancomycin Intermediate Staphylococcus aureus in a Tertiary Care Center of Northern India, Microb Drug Resist, 21, 545, 10.1089/mdr.2015.0004 · DOI
- Y Wang, 2017, Novel Mutation Sites in the Development of Vancomycin- Intermediate Resistance in Staphylococcus aureus, Front Microbiol, 7, 2163, 10.3389/fmicb.2016.02163 · DOI
- VC Doddangoudar, 2011, Tracking changes in the vraSR and graSR two component regulatory systems during the development and loss of vancomycin non-susceptibility in a clinical isolate, Clin Microbiol Infect, 17, 1268, 10.1111/j.1469-0691.2011.03463.x · DOI
- MT Alam, 2014, Dissecting vancomycin-intermediate resistance in Staphylococcus aureus using genome-wide association, Genome Biol Evol, 6, 1174, 10.1093/gbe/evu092 · DOI
- JI Yoo, 2013, Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus, J Microbiol, 51, 160, 10.1007/s12275-013-3088-7 · DOI
- LC Lin, 2018, Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus, Infect Drug Resist, 11, 113, 10.2147/IDR.S148335 · doi:10.2147/idr.s148335
- C Hafer, 2012, Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus, Antimicrob Agents Chemother, 56, 5845, 10.1128/AAC.01139-12 · DOI
- Y Watanabe, 2011, Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus, J Clin Microbiol, 49, 2680, 10.1128/JCM.02144-10 · DOI · Paper page
- M Roch, 2014, Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus, Antimicrob Agents Chemother, 58, 5306, 10.1128/AAC.02574-14 · DOI
- Q Hu, 2016, Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus, Front Microbiol, 7, 1601
- W Gao, 2013, The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus, J Infect Dis, 207, 929, 10.1093/infdis/jis772 · DOI
- K Sieradzki, 2003, Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus, J Bacteriol, 185, 7103, 10.1128/JB.185.24.7103-7110.2003 · DOI · Paper page
- C Park, 2012, Downregulation of RNAIII in vancomycin-intermediate Staphylococcus aureus strains regardless of the presence of agr mutation, J Med Microbiol, 61, 345, 10.1099/jmm.0.035204-0 · doi:10.1099/jmm.0.035204-0
- Y Harigaya, 2011, Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of Staphyloccocus aureus, BMC Infect Dis, 11, 287, 10.1186/1471-2334-11-287 · DOI
Cited by
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158088 · Cited by 412
Metadata
- Authors
- Bakthavatchalam, Y. D., Babu, P., Munusamy, E., Dwarakanathan, H. T., Rupali, P., Zervos, M., John Victor, P., & Veeraraghavan, B.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-12-30
- Volume
- 14
- Issue
- 12
- Pages
- e0227009
- ISSN
- 1932-6203
- Cited by
- 36
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India. https://app.cochat.ai/papers/10.1371/journal.pone.0227009
- The paper
- Bakthavatchalam, Y. D., Babu, P., Munusamy, E., Dwarakanathan, H. T., Rupali, P., Zervos, M., John Victor, P., & Veeraraghavan, B. (2019). Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India. PLOS ONE. https://doi.org/10.1371/journal.pone.0227009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.